Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) major shareholder Guy Levy bought 500,000 shares of Parabilis Medicines stock in a transaction dated Thursday, June 11th. The stock was acquired at an average cost of $20.00 per share, with a total value of $10,000,000.00. Following the completion of the acquisition, the insider directly owned 1,027,000 shares of the company’s stock, valued at approximately $20,540,000. The trade was a 94.88% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
Parabilis Medicines Stock Performance
Shares of PBLS opened at $29.19 on Tuesday. Parabilis Medicines, Inc. has a fifty-two week low of $24.51 and a fifty-two week high of $34.47.
Wall Street Analyst Weigh In
Separately, Wall Street Zen raised Parabilis Medicines to a “hold” rating in a research report on Saturday, June 20th.
Further Reading
- Five stocks we like better than Parabilis Medicines
- The AI Boom Has a Second Act—And It’s Playing Out in Optics
- Gold’s 2026 Rally Has Cracked—Is It Time to Buy the Pullback?
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
